One thing of interest with ketamine is that
oral or intranasal administration of ketamine hydrochloride (ketamine HCl) has been shown to work just as well for depression as IV ketamine (although a study found that with oral or intranasal administration, it took a little longer for the antidepressant effects to kick in, compared to IV).
Oral or intranasal ketamine HCl would be a far more convenient method of administration, compared to having to go to a hospital or clinic to get an IV. Ketamine HCl can be absorbed orally and nasally because it is water soluble, whereas ketamine is not water soluble.
When sold as a street drug (known as "Special K"), it is the ketamine HCl form that is used. This is usually either snorted or injected, and according to
this article, the doses required for a full psychonaut trip on ketamine are around 80 mg if injected, and around 250 mg is snorted intranasally. Obviously for antidepressant or ME/CFS use, you would not want to go on such a trip, so much smaller doses than these are employed. For antidepressant purposes, 50 mg was taken intranasally (see below).
Here are some studies and articles on oral and intranasal ketamine HCl for depression:
•
Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial — this study used around a 40 mg ketamine HCl oral daily dose on patients.
•
A randomized controlled trial of intranasal ketamine in major depressive disorder — this study used 50 mg ketamine HCl intranasally daily on patients
•
Ketamine Nasal Spray For Fast-Acting Depression Relief
•
How to Use Ketamine for Depression and Anxiety
Note that it says
here that:
The bioavailability of ketamine in the body depends on the way it is administered. Compared to IV administration, intramuscular (IM) administration is painful but results in 93% of the bioavailability of IV ketamine. Intranasal (IN) administration results in 25-50% of the bioavailability of IV administration, while oral administration results in only 16-20% of the bioavailability of IV administration
Antidepressant Effects of Ketamine: Mechanism of Action
This study says ketamine antidepressant effect may be mediated via
ketamine's activation of mTOR:
Data suggests that the protracted antidepressant-like effects of ketamine are mediated by molecular alterations to the signaling pathway for the mammalian target of rapamycin (mTOR)
Note however there seems to be an optimum dose, and if you go higher, you lose the mTOR activation effect of ketamine:
There is an inverted U-shape associated with ketamine-induced mTOR activation, with higher doses having no effect.
The study also mentions that:
other antidepressants, including 5-HT2C receptor antagonists, citalopram ... all increase mTORC1 levels
Note that mTORC1 is one of the two enzyme complexes that comprise mTOR.
However, the SSRI, sertraline, and the TCA, imipramine, actually have anti-proliferative effects that are mediated by inhibition of mTOR
This study says ketamine's antidepressant effect may come from:
• mTOR activation
• the production and release of BDNF, a neurotrophic factor essential for neuron development, survival, and synaptic plasticity
• increased BDNF signaling via post-synaptic AMPA receptor stimulation
• via ketamine's inhibition of glycogen synthase kinase-3 (GSK-3)
Hydroxynorketamine (ketamine metabolite) Responsible for the Antidepressant Effects
This 2016 article says that a metabolite of ketamine called
hydroxynorketamine (HNK) is specifically responsible for the antidepressant effect of ketamine.
(2S,6S)-HNK increases mTOR activation (a marker of the antidepressant activity of ketamine) far more potently than ketamine itself.
(2R,6R)-HNK, unlike ketamine, is not an NMDA receptor antagonist, and produces no dissociative or euphoric effects, it has consequently been concluded that the antidepressant effects of ketamine may in fact not be mediated via the NMDA receptor.
Where to Get Ketamine
List of US doctors that can administer ketamine for depression:
•
Ketamine Advocacy Network
In the UK,
ReDKITE is a collaboration between clinicians and researchers exploring the use of low dose ketamine as a possible treatment for treatment resistant depression.
S-Ketamine or R-Ketamine?
As well as the ketamine vs ketamine HCl difference, there is also the issue of whether you use S-ketamine, R-ketamine, or just ketamine (the racemic mixture of both). Ketamine is normally a 50% / 50% racemic mixture of S-ketamine and R-ketamine.
This study found pure S-ketamine may be better than the racemic ketamine in terms of minimizing side effects, as S-ketamine seems to have a lower incidence of side effects such as derealisation and hallucinations.
However,
this article says R-ketamine is more effective than S-ketamine at treating depression.
S-ketamine is also called
Esketamine.
Ketamine has a number of pharmacodynamic effects, and its benefits for depression and/or ME/CFS may derive from several mechanisms:
• Non-competitive antagonist of the NMDA receptor (NMDAR)
• Negative allosteric modulator of the nACh receptor
• Weak agonist of the μ-opioid and κ-opioid receptors (10- and 20-fold less affinity relative to NMDAR, respectively), and very weak agonist of the δ-opioid receptor
• Agonist of the sigma receptor and D2 receptor
• Weak mACh receptor antagonist (10- to 20-fold less affinity relative to NMDAR)
• Inhibitor of the reuptake of serotonin, dopamine, and norepinephrine
• Voltage-gated sodium channel and L-type calcium channel blocker, and HCN1 cation channel blocker
• Inhibitor of nitric oxide synthase
Source:
Ketamine - Wikipedia
The ketamine binding site on the NMDA receptor is shown in the following diagram:
Note that dizocilpine (MK-801), which also acts at the same ketamine site on the NMDA receptor, does not have antidepressant effects (see
this rat study).
Note: this post was updated on 19 Jan 2017.